# Japan Vascular Embolization Market > Japan Vascular Embolization Market Research Report By Embolization Technique (Coiling Devices, Non-coiling Devices) and By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, Other) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 16.09% - **2024:** $ 78.31 Million - **2025:** $ 90.91 Million - **2035:** $ 404.18 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Terumo (JP), Johnson & Johnson (US), Stryker (US), B. Braun Melsungen AG (DE), Cook Medical (US), Abbott Laboratories (US) **Report ID:** MRFR/MED/50296-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/japan-vascular-embolization-market-52054 --- ## Market Summary ## **Japan Vascular Embolization Market Overview** As per MRFR analysis, the Japan Vascular Embolization Market Size was estimated at 71.31 (USD Million) in 2023. The Japan Vascular Embolization Market Industry is expected to grow from 78.38(USD Million) in 2024 to 295.62 (USD Million) by 2035. The Japan Vascular Embolization Market CAGR (growth rate) is expected to be around 12.827% during the forecast period (2025 - 2035). ### **Key Japan Vascular Embolization Market Trends Highlighted** Advancements in medical technology and an increasing emphasis on minimally invasive procedures are driving significant trends in the Japan Vascular Embolization Market. Innovative embolisation devices, including biocompatible materials and advanced imaging techniques, are enhancing the treatment outcomes of patients with a variety of vascular conditions. An important market driver is the increasing prevalence of diseases such as uterine fibroids and specific malignancies, which has resulted in a greater demand for effective embolisation treatments. In addition, the vascular embolisation market is further stimulated by the ageing population in Japan, which is among the highest in the world. This necessitates the implementation of advanced healthcare solutions.  There are significant opportunities to be investigated in the field of education and training for healthcare professionals in Japan, ensuring that they are endowed with the most recent knowledge on the latest procedures and technologies in vascular embolisation. Healthcare institutions and technology firms can collaborate to develop innovative solutions that are customised to meet the specific requirements of the local market, thereby promoting market expansion. Patients have become increasingly informed about their treatment options, and there has been a notable rise in awareness of the advantages of vascular embolisation in recent years.  Japan's government has prioritised the improvement of medical services and access to advanced therapies, which is progressively changing the public's perception of embolisation as the preferred treatment method.In addition, regulatory bodies are modifying their policies to promote the implementation of innovative technologies and techniques in embolisation, thereby creating an environment that is conducive to market expansion. In Japan, the vascular embolisation market is being driven forward by the general emphasis on patient-centered practices and quality healthcare. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ## **Japan Vascular Embolization Market Drivers** Increasing Prevalence of Cancer and Cardiovascular Diseases Japan has seen a significant rise in the prevalence of cancer and cardiovascular diseases, leading to an increased demand for vascular embolization procedures. According to the Ministry of Health, Labour and Welfare of Japan, cancer remains the leading cause of death in Japan, with approximately 1 in 3 individuals predicted to be diagnosed with cancer in their lifetime. This alarming statistic has prompted healthcare organizations such as the Japan Cancer Society to advocate for advanced treatment options, including vascular embolization.Such treatments are essential for managing tumors and addressing various cardiovascular complications, thus driving growth in the Japan Vascular Embolization Market. Furthermore, the aging population in Japan, where around 28% of the population will be over 65 years by 2025, adds to the increased incidence of these health conditions, reinforcing the need for targeted and effective embolization therapies. Technological Advances in Embolization Devices The Japan Vascular Embolization Market is experiencing accelerated growth due to rapid technological advancements in embolization devices. Investment in Research and Development (R&D) by leading manufacturers such as Terumo Corporation and Cook Medical has led to the launch of innovative embolization products, including bioresorbable microspheres and advanced catheter systems that enhance the efficacy and safety of procedures. The Japan Medical Device Industry Association reports a marked increase in the approval of new medical devices in recent years, facilitating better clinical outcomes and patient satisfaction.This commitment to innovation makes vascular embolization an increasingly viable option for clinicians and patients alike, contributing significantly to the growth trajectory of the market. Government Initiatives and Support for Healthcare Infrastructure The Japanese government has implemented various initiatives aimed at enhancing healthcare infrastructure, which directly benefits the Japan Vascular Embolization Market Industry. The Health Care System Reform plan, initiated to improve patient access to advanced medical technologies, includes provisions for financial support and subsidies to hospitals and clinics that adopt state-of-the-art treatment modalities. Furthermore, the establishment of a regulatory framework that encourages innovation in medical device development validates the government's commitment to boosting healthcare services.As investment in healthcare rises, more institutions are expected to integrate vascular embolization procedures into their treatment protocols, thus propelling market growth. ## **Japan Vascular Embolization Market Segment Insights** ### **Vascular Embolization Market Embolization Technique Insights** In the Japan Vascular Embolization Market, the Embolization Technique plays a crucial role in the management of various vascular conditions, offering a minimally invasive approach to treatment. This segment is primarily categorized into two prominent categories: Coiling Devices and Non-coiling Devices. Coiling Devices, which are commonly employed to occlude aneurysms and are also used in different types of vascular deformities, represent a significant portion of this market. Their ability to provide targeted treatment while minimizing collateral damage to surrounding tissues ensures they remain popular among healthcare providers in Japan.Meanwhile, Non-coiling Devices serve a vital purpose as well, their flexibility allowing for diverse applications in the embolization process.  These devices are crucial in treating conditions such as arteriovenous malformations and tumors, showcasing versatility in approaches tailored to individual patient needs. The advancements in technology around embolization techniques, paired with the increasing awareness of minimally invasive procedures, are acting as robust growth drivers for the Embolization Technique segment. Furthermore, with an aging population in Japan, there is a rising incidence of conditions requiring procedure intervention, leading to a growing demand for effective embolization solutions. The Japanese government also encourages advancements in medical technology through various initiatives, promoting the development of innovative devices that can enhance clinical outcomes and patient safety, a factor contributing positively to market dynamics. As the landscape evolves, manufacturers are increasingly focusing on improving device efficacy and patient comfort, which presents substantial opportunities for growth in this segment. Overall, the Embolization Technique segment is positioned for significant growth, driven by technological advancements, evolving patient demographics, and increasing acceptance of minimally invasive procedures among healthcare professionals in Japan. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Revie****w** ### **Vascular Embolization Market Application Insights** The Japan Vascular Embolization Market has been segmented by Application into various key areas, each playing a crucial role in the overall healthcare landscape. Peripheral Vascular Disease emerges as a dominant application due to the rising incidence of circulatory problems among the aging population in Japan, highlighting the urgent need for effective treatment options. Oncology represents another significant segment as the burden of cancer continues to rise, leading to increased demand for vascular embolization techniques that aid in tumor management and minimize the side effects of conventional therapies. Neurology gains attention due to advancements in embolization technologies to treat conditions such as intracranial aneurysms, providing innovative solutions to complex neurological disorders. The Urology sector is also noteworthy, with vascular embolization techniques becoming increasingly recognized for their role in addressing conditions like kidney tumors. Additionally, the 'Other' category encompasses diverse applications that utilize embolization methods across various medical specialties, thus contributing to the market growth. Collectively, these segments reflect the evolution of treatment modalities in Japan's healthcare system, driven by technological advancements and a growing emphasis on minimally invasive procedures. ## **Japan Vascular Embolization Market Key Players and Competitive Insights** The Japan Vascular Embolization Market is characterized by a diverse landscape of companies vying for a significant market share through innovation, product development, and strategic partnerships. This market serves a range of medical needs, from oncology to treating various vascular malformations, thereby attracting attention from both established corporations and emerging firms. The competitive dynamics are driven by factors such as technological advancements, regulatory frameworks, pricing strategies, and the growing prevalence of conditions requiring embolization procedures.  As the healthcare sector becomes increasingly focused on minimally invasive techniques, companies are adapting their portfolios to align with trends in vascular interventions, thereby intensifying competition and shaping market dynamics. Bayer plays a significant role in the Japan Vascular Embolization Market, leveraging its extensive research and development capabilities. The company is recognized for its strong commitment to innovation and excellence, which is evident in its comprehensive range of embolization products designed to cater to the evolving needs of healthcare professionals. Bayer's strength lies in its longstanding reputation for quality and efficacy, which helps in building trust among medical practitioners and patients alike.  The company employs a robust distribution network throughout Japan, ensuring accessibility to their products in both urban and rural healthcare settings. Additionally, Bayer's strategic collaborations with local healthcare institutions enhance its market presence, allowing for tailored solutions that meet specific regional healthcare challenges.AngioDynamics is another key player in the Japan Vascular Embolization Market, providing a variety of innovative products aimed at improving patient outcomes in minimally invasive surgeries. The company's offerings include radiofrequency ablation devices, embolic agents, and vascular access systems, which are significant in the context of vascular treatments in Japan. AngioDynamics has established a noteworthy market presence through its focus on high-quality, results-driven solutions, backed by educational initiatives aimed at enhancing clinician knowledge.  The company's strengths include a strong emphasis on customer service, responsive product support, and ongoing research to expand its product line based on emerging clinical needs. Furthermore, AngioDynamics has engaged in mergers and acquisitions that have bolstered its technological capabilities and expanded its resources, allowing it to respond effectively to demand in the Japanese healthcare landscape. **Key Companies in the Japan Vascular Embolization Market Include** ## **Japan Vascular Embolization Market Industry Developments** In recent months, the Japan Vascular Embolization Market has seen significant growth and activity, particularly among major companies such as Bayer, AngioDynamics, and Terumo. Notably, reports indicate that Johnson and Johnson has enhanced its product offerings through strategic collaborations, thereby strengthening its market position. In February 2023, Medtronic unveiled a new vascular embolization product designed to improve patient outcomes, which is anticipated to enhance its competitive edge. Additionally, Cook Medical in March 2022 expanded its line of embolization devices tailored for complex vascular conditions, showcasing innovation in this sector. In terms of market valuation, the overall growth has been attributed to an increasing prevalence of vascular diseases among the aging population in Japan, along with advancements in minimally invasive procedures, reflecting a shift in treatment paradigms.  Furthermore, there have been no major mergers or acquisition activities reported among the selected companies within this timeframe, indicating a stable yet competitive market landscape. Overall, the current trends underscore a dynamic environment focused on technological advancements and collaborative efforts to meet the evolving needs of healthcare professionals and patients in Japan. ## **Japan Vascular Embolization Market Segmentation Insights** ### **Vascular Embolization Market Embolization Technique****Outlook** ### **Vascular Embolization Market Application****Outlook** ## Market Drivers ### Increased Healthcare Expenditure Japan's rising healthcare expenditure is a significant driver for the vascular embolization market. The government has been investing heavily in healthcare infrastructure and services, aiming to improve access to advanced medical treatments. This financial commitment is reflected in the growing number of hospitals equipped with state-of-the-art facilities for vascular interventions. As healthcare spending continues to rise, the vascular embolization market is poised for growth, as more patients gain access to innovative treatment options. This trend indicates a shift towards prioritizing advanced medical technologies and procedures, including embolization. ### Supportive Reimbursement Policies Supportive reimbursement policies in Japan are fostering growth in the vascular embolization market. The government has been implementing policies that facilitate coverage for advanced medical procedures, including embolization. This financial support encourages healthcare providers to adopt these innovative treatments, as they are more likely to be reimbursed for the costs associated with them. As reimbursement frameworks evolve to support the use of embolization techniques, the vascular embolization market is expected to expand, making these procedures more accessible to a broader patient population. ### Rising Incidence of Vascular Diseases The increasing prevalence of vascular diseases in Japan is a primary driver for the vascular embolization market. Conditions such as aneurysms, arteriovenous malformations, and peripheral vascular diseases are becoming more common, necessitating effective treatment options. According to recent health statistics, vascular diseases account for a significant portion of morbidity and mortality in the country. This trend is likely to propel the demand for minimally invasive procedures, including embolization, as they offer reduced recovery times and lower complication rates. The vascular embolization market is expected to benefit from this rising incidence, as healthcare providers seek advanced solutions to address these growing health challenges. ### Advancements in Medical Imaging Technologies Innovations in medical imaging technologies are transforming the landscape of the vascular embolization market. Enhanced imaging modalities, such as 3D angiography and intravascular ultrasound, allow for more precise diagnosis and treatment planning. These advancements facilitate better visualization of vascular structures, leading to improved patient outcomes. As hospitals and clinics in Japan adopt these technologies, the demand for embolization procedures is likely to increase. The vascular embolization market stands to gain from this trend, as practitioners leverage advanced imaging to enhance procedural accuracy and efficacy, ultimately benefiting patient care. ### Growing Awareness of Minimally Invasive Procedures There is a notable increase in awareness regarding the benefits of minimally invasive procedures among both healthcare professionals and patients in Japan. This growing recognition is driving the vascular embolization market, as patients increasingly prefer treatments that offer shorter recovery times and reduced hospital stays. Educational initiatives and marketing efforts by healthcare providers are contributing to this trend, highlighting the advantages of embolization techniques. As awareness continues to spread, the vascular embolization market is likely to experience heightened demand, as more patients opt for these less invasive treatment options. ## Future Outlook The [Vascular Embolization Market](https://www.marketresearchfuture.com/reports/vascular-embolization-market-11872) in Japan is projected to grow at a 16.09% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of vascular diseases, and rising healthcare expenditure. **New opportunities:** - Development of biodegradable embolic agents for enhanced patient safety. - Expansion of telemedicine platforms for remote embolization consultations. - Investment in AI-driven imaging technologies to improve procedural accuracy. By 2035, the vascular embolization market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Technique: Coiling Devices (Largest) vs. Non-coiling Devices (Fastest-Growing) In the Japan vascular embolization market, coiling devices represent the largest segment, capturing a substantial portion of the market share. This dominance is attributed to their effectiveness and established usage in various vascular procedures, making them a preferred choice among healthcare professionals and hospitals. Conversely, non-coiling devices are emerging rapidly, driven by innovations and increasing clinical adoption in specific treatments, marking a significant shift in preference among practitioners. The growth trends for the technique segment are significantly influenced by advancements in technology and increased investment in healthcare infrastructure. Non-coiling devices are experiencing a surge in demand as they offer unique solutions for specific vascular conditions, leading to their fastest growth trajectory. Additionally, the rising prevalence of vascular diseases in Japan has prompted a broader application and acceptance of both device types, thus enhancing their market potential. Technique: Coiling Devices (Dominant) vs. Non-coiling Devices (Emerging) Coiling devices, as the dominant segment in the Japan vascular embolization market, are renowned for their reliability and effectiveness in achieving favorable outcomes for patients. They are widely adopted in clinical practice due to their procedural success rate and safety profile. On the other hand, non-coiling devices represent an emerging trend, showcasing innovative designs and capabilities that cater to specific embolization needs. These devices are increasingly recognized for their potential to offer alternatives to traditional methods, attracting attention from both healthcare providers and patients. The ongoing technological advancements are expected to enhance their market position, creating a complementary balance between coiling and non-coiling devices in addressing diverse vascular issues. ### By Application: Oncology (Largest) vs. Peripheral Vascular Disease (Fastest-Growing) In the Japan vascular embolization market, Oncology emerges as the largest segment due to its critical role in cancer treatment, leading to a significant market share. This predominance is influenced by the increasing incidence of cancer and a higher preference for minimally invasive procedures in oncological interventions, making it a focal point for healthcare investments. On the other hand, Peripheral Vascular Disease is recognized as the fastest-growing segment, primarily driven by the rising prevalence of lifestyle-related health issues, which emphasize the need for effective vascular treatments. Growth trends within the segment have been buoyed by technological advancements, increasing awareness among patients and healthcare providers, and supportive government policies aimed at improving healthcare access. The innovative use of embolization techniques for treating various conditions has revolutionized patient outcomes. These trends illustrate a dynamic landscape where both Oncology and Peripheral Vascular Disease are pivotal for shaping the future of the Japan vascular embolization market. Oncology (Dominant) vs. Peripheral Vascular Disease (Emerging) Oncology stands as the dominant application within the Japan vascular embolization market, driven by a strong demand for effective cancer interventions and the integration of advanced embolization techniques that enhance treatment efficacy. The segment is characterized by continuous innovations and the development of new technologies that facilitate improved patient outcomes. Conversely, Peripheral Vascular Disease is emerging rapidly, fueled by rising health awareness and the growing burden of vascular-related ailments among the aging population. This segment is seeing increased attention from manufacturers and healthcare providers who are keen on introducing specialized embolization solutions that cater specifically to vascular conditions, thereby reshaping clinical practices and market dynamics. ## Competitive Benchmarking The vascular embolization market in Japan is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Medtronic (US), Terumo (JP), and Boston Scientific (US) are at the forefront, leveraging their technological expertise and market presence to drive growth. Medtronic (US) focuses on enhancing its product portfolio through continuous innovation, while Terumo (JP) emphasizes local manufacturing capabilities to cater to specific regional needs. Boston Scientific (US) appears to be pursuing aggressive market penetration strategies, which collectively contribute to a dynamic competitive environment.The market structure is moderately fragmented, with several players vying for market share. Companies are adopting various business tactics, such as localizing manufacturing and optimizing supply chains, to enhance operational efficiency. This fragmentation allows for a diverse range of products and services, although the influence of major players remains significant. The collective strategies of these companies indicate a trend towards collaboration and innovation, which is likely to reshape the market landscape. In October Terumo (JP) announced the launch of a new embolization device designed specifically for the treatment of vascular malformations. This strategic move not only enhances Terumo's product offerings but also positions the company as a leader in addressing niche medical needs. The introduction of this device is expected to strengthen Terumo's market presence and cater to the growing demand for specialized embolization solutions. In September Boston Scientific (US) entered into a partnership with a leading Japanese healthcare provider to expand its distribution network for embolization products. This collaboration is indicative of Boston Scientific's commitment to enhancing its market reach and improving patient access to innovative therapies. By aligning with local healthcare entities, the company is likely to gain valuable insights into market dynamics and patient preferences, further solidifying its competitive position. In August Medtronic (US) completed the acquisition of a smaller medical device firm specializing in embolization technologies. This acquisition is seen as a strategic effort to bolster Medtronic's capabilities in the vascular space, allowing for the integration of advanced technologies into its existing product lines. The move is expected to enhance Medtronic's competitive edge by expanding its technological portfolio and accelerating the development of next-generation embolization solutions. As of November the competitive trends in the vascular embolization market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and respond to evolving market demands. ## Recent News & Developments In recent months, the Japan Vascular Embolization Market has seen significant growth and activity, particularly among major companies such as Bayer, AngioDynamics, and Terumo. Notably, reports indicate that Johnson and Johnson has enhanced its product offerings through strategic collaborations, thereby strengthening its market position. In February 2023, Medtronic unveiled a new vascular embolization product designed to improve patient outcomes, which is anticipated to enhance its competitive edge. Additionally, Cook Medical in March 2022 expanded its line of embolization devices tailored for complex vascular conditions, showcasing innovation in this sector. In terms of market valuation, the overall growth has been attributed to an increasing prevalence of vascular diseases among the aging population in Japan, along with advancements in minimally invasive procedures, reflecting a shift in treatment paradigms.  Furthermore, there have been no major mergers or acquisition activities reported among the selected companies within this timeframe, indicating a stable yet competitive market landscape. Overall, the current trends underscore a dynamic environment focused on technological advancements and collaborative efforts to meet the evolving needs of healthcare professionals and patients in Japan. ## Report Scope | MARKET SIZE 2024 | 78.31(USD Million) | | --- | --- | | MARKET SIZE 2025 | 90.91(USD Million) | | MARKET SIZE 2035 | 404.18(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 16.09% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Terumo (JP), Johnson & Johnson (US), Stryker (US), B. Braun Melsungen AG (DE), Cook Medical (US), Abbott Laboratories (US) | | Segments Covered | Technique, Application | | Key Market Opportunities | Advancements in minimally invasive techniques enhance growth potential in the vascular embolization market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in Japan's vascular embolization market. | | Countries Covered | Japan | ## Frequently Asked Questions **Q: What was the market valuation of the Japan vascular embolization market in 2024?** A: The market valuation was $78.31 Million in 2024. **Q: What is the projected market valuation for the Japan vascular embolization market by 2035?** A: The projected valuation for 2035 is $404.18 Million. **Q: What is the expected CAGR for the Japan vascular embolization market during the forecast period 2025 - 2035?** A: The expected CAGR is 16.09% during the forecast period 2025 - 2035. **Q: Which companies are considered key players in the Japan vascular embolization market?** A: Key players include Medtronic, Boston Scientific, Terumo, Johnson & Johnson, Stryker, B. Braun Melsungen AG, Cook Medical, and Abbott Laboratories. **Q: What are the two main segments of the Japan vascular embolization market?** A: The two main segments are Technique and Application. **Q: What was the valuation range for coiling devices in the Japan vascular embolization market?** A: The valuation range for coiling devices was $30.0 Million to $150.0 Million. **Q: What is the valuation range for non-coiling devices in the Japan vascular embolization market?** A: The valuation range for non-coiling devices was $48.31 Million to $254.18 Million. **Q: Which application segment had the highest valuation in 2024?** A: The Oncology application segment had the highest valuation, ranging from $20.0 Million to $100.0 Million. **Q: What is the projected growth trend for the peripheral vascular disease application segment by 2035?** A: The peripheral vascular disease application segment is projected to grow from $15.66 Million to $80.0 Million by 2035. **Q: How does the market for neurology applications compare to other segments in 2024?** A: In 2024, the neurology application segment ranged from $18.0 Million to $90.0 Million, indicating a competitive position among other segments. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/japan-vascular-embolization-market-52054*